Iqvia Holdings Stock News

IQVIA Holdings Inc. (NYSE:IQV) Director John Connaughton sold 555,094 shares of the companys stock in a transaction that occurred on Monday, November 29th. The stock was sold at an average price of $262.60, for a total transaction of $145,767,684.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can []

Equities analysts forecast that IQVIA Holdings Inc. (NYSE:IQV) will post earnings of $2.43 per share for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have issued estimates for IQVIAs earnings, with estimates ranging from $2.40 to $2.47. IQVIA posted earnings of $2.11 per share in the same quarter last year, which indicates []

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, is launching new Research Nursing and Phlebotomy services. These new services offer patients participating in clinical trials access to a global network of high-quality, credentialed professionals that provide compassionate protocol-required care within their own homes. We believe combining clinical

The Zacks Technology Services industry is likely to benefit from COVID-19-driven dependency on technology, increased digitization and adoption of the multi-cloud model. IQV, STX and BCOR are well posi

Wall Street brokerages expect IQVIA Holdings Inc. (NYSE:IQV) to announce $3.59 billion in sales for the current quarter, according to Zacks. Seven analysts have issued estimates for IQVIAs earnings, with the lowest sales estimate coming in at $3.58 billion and the highest estimate coming in at $3.61 billion. IQVIA reported sales of $3.30 billion in []

Private Advisor Group LLC boosted its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 109.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 74,219 shares of the medical research companys stock after purchasing an additional 38,741 shares during the period. Private Advisor Group LLCs holdings []

FNY Investment Advisers LLC purchased a new stake in shares of IQVIA Holdings Inc. (NYSE:IQV) during the third quarter, Holdings Channel reports. The fund purchased 271 shares of the medical research companys stock, valued at approximately $64,000. Other institutional investors have also added to or reduced their stakes in the company. Perennial Advisors LLC bought []

IQVIA Holdings found using ticker (IQV) have now 18 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 320 and 261 and has a mean target at 300.22. With the stocks previous close at 265.27 this indicates there is a potential upside of 13.2%. There is a 50 day moving average of 252.64 and the 200 day moving average is 234.73. The market capitalisation for the company is $50,694m. Company Website: /> [stock_market_widget type="chart" symbol="IQV" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients'' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

Cypress Wealth Services LLC lowered its position in IQVIA Holdings Inc. (NYSE:IQV) by 15.8% during the third quarter, according to its most recent filing with the SEC. The firm owned 1,155 shares of the medical research companys stock after selling 217 shares during the period. Cypress Wealth Services LLCs holdings in IQVIA were worth $277,000 []

IQVIA (NYSE:IQV) had its target price boosted by Mizuho from $282.00 to $290.00 in a research note published on Thursday, The Fly reports. Mizuho currently has a buy rating on the medical research companys stock. IQV has been the topic of a number of other reports. Evercore ISI reaffirmed an outperform rating on shares of []

Pensionfund DSM Netherlands purchased a new stake in IQVIA Holdings Inc. (NYSE:IQV) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,000 shares of the medical research companys stock, valued at approximately $719,000. A number of other hedge funds and other institutional []

IQVIA (NYSE:IQV) had its price target lifted by KeyCorp from $270.00 to $290.00 in a research note issued to investors on Wednesday, The Fly reports. The brokerage currently has an overweight rating on the medical research companys stock. KeyCorp also issued estimates for IQVIAs FY2022 earnings at $9.20 EPS. A number of other equities research []

IQVIA Holdings Inc. (NYSE:IQV) William Blair increased their FY2022 EPS estimates for IQVIA in a research note issued on Wednesday, November 17th. William Blair analyst J. Kreger now forecasts that the medical research company will post earnings per share of $9.36 for the year, up from their prior estimate of $9.35. William Blair also []

IQVIA Holdings Inc. (NYSE:IQV) Stock analysts at Jefferies Financial Group dropped their FY2021 earnings per share estimates for shares of IQVIA in a research note issued on Wednesday, November 17th. Jefferies Financial Group analyst D. Windley now forecasts that the medical research company will earn $8.24 per share for the year, down from their []

Allred Capital Management LLC decreased its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 4.4% during the 3rd quarter, HoldingsChannel reports. The fund owned 1,636 shares of the medical research companys stock after selling 76 shares during the quarter. Allred Capital Management LLCs holdings in IQVIA were worth $392,000 at the end of the []